Acetylglucosamine: Clinical Trials

3 trials of Acetylglucosamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Unknown 1
Phase 31Unknown 1

Follow Acetylglucosamine: new trials by email Literature Review of Acetylglucosamine trials Research Report on Acetylglucosamine

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral N-acetylglucosamine in Crohn's Disease
N-Acetylglucosamine (GlcNAc) - Crohns Disease
Phase 2Not yet recruitingJohns Hopkins University402027-01-052026-11-05
Therapeutic Approaches to Malnutrition Enteropathy
Colostrum high protein powder (Neovite), N-Acetyl Glucosamine (GInNAC), Teduglutide - Severe Acute Malnutrition
Phase 2CompletedQueen Mary University of London1252020-05-042021-09-27
Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
N-acetyl-D-glucosamine, placebo - Irritable Bowel Syndrome
Phase 2 / Phase 3UnknownThird Military Medical University1802013-04-012015-07-24

Conditions studied

Abdominal Pain (1)  ·  Crohn Disease (1)  ·  Diarrhea (1)  ·  Irritable Bowel Syndrome (1)  ·  Severe Acute Malnutrition (1)

Sponsors

Johns Hopkins University (1)  ·  Queen Mary University of London (1)  ·  Third Military Medical University (1)

Countries

China (1)  ·  United States (1)  ·  Zambia (1)  ·  Zimbabwe (1)

Top investigators

Andrew Prendergast, PhD (1)  ·  Beatrice Amadi, MD (1)  ·  Joanna Melia, MD (1)  ·  Junkang Liu, Doctor (1)  ·  Mutsa Bwakura-Dangarembizi, MB (1)  ·  Paul Kelly, MD (1)

Results publications

PMID 31727642, PMID 38632262

NIH funding

R01DK141870 (1)